Last reviewed · How we verify
Ciclosprin A
Ciclosprin A is an immunosuppressive agent that inhibits the activity of T cells.
Ciclosprin A is an immunosuppressive agent that inhibits the activity of T cells. Used for Prevention of organ rejection in transplant patients.
At a glance
| Generic name | Ciclosprin A |
|---|---|
| Sponsor | Hospices Civils de Lyon |
| Drug class | Immunosuppressant |
| Target | T cell receptor |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | Phase 2 |
Mechanism of action
Ciclosprin A works by binding to the T cell receptor, preventing the activation of T cells and subsequent immune response. This mechanism is crucial in preventing organ rejection in transplant patients.
Approved indications
- Prevention of organ rejection in transplant patients
Common side effects
- Nausea
- Diarrhea
- Headache
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |